Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study
Authors:
Abstract
Background: Blood or bone marrow transplantation (BMT) survivors with frailty are at a higher risk of subsequent mortality. Longitudinal trends in the frailty state are not known and could help identify vulnerable subpopulations at risk of subsequent adverse events.Methods: This study included a cohort of 470 autologous and allogeneic BMT recipients who had survived ≥2 years after BMT and completed a baseline questionnaire (t1) at a median of 7.3 years after BMT and a follow‐up questionnaire (t2) 13.2 years after t1. The main outcome was change in frailty state between t1 and t2. Frailty phenotype was defined as exhibiting ≥3 of the following characteristics: clinically underweight, exhaustion, low energy expenditure, slow walking speed, and muscle weakness. The following categories of change in frailty state were evaluated: worsened, improved, and stable.Results: Of the 470 participants, 36.4% were aged ≥60 years at t1, and 50.6% were men. The prevalence of frailty increased from 4.8% at t1 to 9.6% at t2. Worsening was observed in 18.8% of patients, and improvement was reported in 9.7%. Pre‐BMT exposure to vincristine (odds ratio [OR], 2.1; 95% CI, 1.3‐3.39) was associated with worsening. Female sex (OR, 1.5; 95% CI, 0.93‐2.4) was associated with a trend toward worsening. Pre‐BMT exposure to vincristine (OR, 2.79; 95% CI, 1.44‐5.43), a history of chronic graft‐versus‐host disease (OR, 2.58; 95% CI, 1.2‐5.5), and grade 3 and 4 chronic health conditions at t1 (OR, 2.1; 95% CI, 1.08‐4.33) were associated with frailty at t2.Conclusions: In a cohort of BMT survivors who were followed longitudinally for a median of 20.6 years from BMT, the frailty status worsened for approximately20% over a 13‐year timespan. BMT survivors who are at risk for worsening frailty could benefit from targeted interventions.Keywords
Funding Information
- National Cancer Institute (R01 CA078938)
- Leukemia and Lymphoma Society (R6502‐16)
This publication has 18 references indexed in Scilit:
- Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation PatientsJAMA Oncology, 2016
- A Multicomponent Exercise Intervention that Reverses Frailty and Improves Cognition, Emotion, and Social Networking in the Community-Dwelling Frail Elderly: A Randomized Clinical TrialJournal of the American Medical Directors Association, 2016
- Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled TrialThe American Journal of Medicine, 2015
- Physiologic Frailty As a Sign of Accelerated Aging Among Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort StudyJournal of Clinical Oncology, 2013
- Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor StudyBone Marrow Transplantation, 2011
- Frailty Syndrome: A Transitional State in a Dynamic ProcessGerontology, 2009
- Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and CareThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2004
- A Program to Prevent Functional Decline in Physically Frail, Elderly Persons Who Live at HomeNew England Journal of Medicine, 2002
- Validation of self-reported complications by bone marrow transplantation survivorsBone Marrow Transplantation, 2000
- High-Intensity Strength Training in NonagenariansJAMA, 1990